Nyxoah Enterprise Value Over E B I T D A from 2010 to 2025

NYXH Stock  USD 10.00  0.36  3.47%   
Nyxoah's Enterprise Value Over EBITDA is increasing with slightly volatile movements from year to year. Enterprise Value Over EBITDA is predicted to flatten to -2.44. For the period between 2010 and 2025, Nyxoah, Enterprise Value Over EBITDA quarterly trend regression had mean deviation of  16.76 and range of 67.0382. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(2.32)
Current Value
(2.44)
Quarterly Volatility
20.00708054
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nyxoah financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nyxoah's main balance sheet or income statement drivers, such as Net Interest Income of 1.3 M, Interest Income of 1.4 M or Depreciation And Amortization of 2.8 M, as well as many indicators such as Price To Sales Ratio of 29.5, Dividend Yield of 0.0 or PTB Ratio of 1.31. Nyxoah financial statements analysis is a perfect complement when working with Nyxoah Valuation or Volatility modules.
  
Check out the analysis of Nyxoah Correlation against competitors.
For more detail on how to invest in Nyxoah Stock please use our How to Invest in Nyxoah guide.

Latest Nyxoah's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Nyxoah over the last few years. It is Nyxoah's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nyxoah's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Nyxoah Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(30.99)
Geometric Mean19.85
Coefficient Of Variation(64.55)
Mean Deviation16.76
Median(40.80)
Standard Deviation20.01
Sample Variance400.28
Range67.0382
R-Value0.70
Mean Square Error220.52
R-Squared0.49
Significance0
Slope2.93
Total Sum of Squares6,004

Nyxoah Enterprise Value Over E B I T D A History

2025 -2.44
2024 -2.32
2023 -2.58
2022 -4.1
2021 -14.54
2020 -25.9
2019 -69.36

About Nyxoah Financial Statements

Investors use fundamental indicators, such as Nyxoah's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Nyxoah's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(2.32)(2.44)

Currently Active Assets on Macroaxis

When determining whether Nyxoah offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nyxoah's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nyxoah Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nyxoah Stock:
Check out the analysis of Nyxoah Correlation against competitors.
For more detail on how to invest in Nyxoah Stock please use our How to Invest in Nyxoah guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nyxoah. If investors know Nyxoah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nyxoah listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.81)
Revenue Per Share
0.166
Quarterly Revenue Growth
0.297
Return On Assets
(0.23)
Return On Equity
(0.50)
The market value of Nyxoah is measured differently than its book value, which is the value of Nyxoah that is recorded on the company's balance sheet. Investors also form their own opinion of Nyxoah's value that differs from its market value or its book value, called intrinsic value, which is Nyxoah's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nyxoah's market value can be influenced by many factors that don't directly affect Nyxoah's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nyxoah's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nyxoah is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nyxoah's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.